Semi-Automated Segmentation of Bone Metastases from Whole-Body MRI: Reproducibility of Apparent Diffusion Coefficient Measurements.
Alberto ColomboGiulia SaiaAlcide A AzzenaAlice RossiFabio ZugniPaola PricoloPaul Eugene SummersGiulia MarvasoRobert GrimmMassimo BellomiBarbara Alicja Jereczek-FossaAnwar R PadhaniGiuseppe PetraliaPublished in: Diagnostics (Basel, Switzerland) (2021)
Using semi-automated software simplifies quantitative analysis of the visible burden of disease on whole-body MRI diffusion-weighted images. To establish the intra- and inter-observer reproducibility of apparent diffusion coefficient (ADC) measures, we retrospectively analyzed data from 20 patients with bone metastases from breast (BCa; n = 10; aged 62.3 ± 14.8) or prostate cancer (PCa; n = 10; aged 67.4 ± 9.0) who had undergone examinations at two timepoints, before and after hormone-therapy. Four independent observers processed all images twice, first segmenting the entire skeleton on diffusion-weighted images, and then isolating bone metastases via ADC histogram thresholding (ADC: 650-1400 µm2/s). Dice Similarity, Bland-Altman method, and Intraclass Correlation Coefficient were used to assess reproducibility. Inter-observer Dice similarity was moderate (0.71) for women with BCa and poor (0.40) for men with PCa. Nonetheless, the limits of agreement of the mean ADC were just ±6% for women with BCa and ±10% for men with PCa (mean ADCs: 941 and 999 µm2/s, respectively). Inter-observer Intraclass Correlation Coefficients of the ADC histogram parameters were consistently greater in women with BCa than in men with PCa. While scope remains for improving consistency of the volume segmented, the observer-dependent variability measured in this study was appropriate to distinguish the clinically meaningful changes of ADC observed in patients responding to therapy, as changes of at least 25% are of interest.
Keyphrases
- diffusion weighted imaging
- contrast enhanced
- diffusion weighted
- deep learning
- magnetic resonance imaging
- convolutional neural network
- prostate cancer
- computed tomography
- magnetic resonance
- middle aged
- optical coherence tomography
- end stage renal disease
- machine learning
- artificial intelligence
- high throughput
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- high resolution
- high intensity
- chronic kidney disease
- data analysis
- electronic health record
- mesenchymal stem cells
- mass spectrometry